Literature DB >> 31604679

Timeless-Stimulated miR-5188-FOXO1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in Breast Cancer.

Yujiao Zou1, Xian Lin2, Junguo Bu3, Zelong Lin2, Yanjuan Chen2, Yunhui Qiu2, Haiyue Mo2, Yao Tang2, Weiyi Fang4, Ziqing Wu5.   

Abstract

MicroRNAs (miRNAs) play an essential role in the self-renewal of breast cancer stem cells (BCCs). Our study aimed to clarify the role of proto-oncogene c-Jun-regulated miR-5188 in breast cancer progression and its association with Timeless-mediated cancer stemness. In the present study, we showed that miR-5188 exerted an oncogenic effect by inducing breast cancer stemness, proliferation, metastasis, and chemoresistance in vitro and in vivo. The mechanistic analysis demonstrated that miR-5188 directly targeted FOXO1, which interacted with β-catenin in the cytoplasm, facilitated β-catenin degradation, and impaired the nuclear accumulation of β-catenin, thus stimulating the activation of known Wnt targets, epithelial-mesenchymal transition (EMT) markers, and key regulators of cancer stemness. Moreover, miR-5188 potentiated Wnt/β-catenin/c-Jun signaling to promote breast cancer progression. Interestingly, c-Jun enhanced miR-5188 transcription to form a positive regulatory loop, and Timeless interacted with Sp1/c-Jun to induce miR-5188 expression by promoting c-Jun-mediated transcription, which further activated miR-5188-FOXO1/β-catenin-c-Jun loop and facilitated breast cancer progression. Importantly, miR-5188 was upregulated in breast cancer and was positively correlated with poor patient prognosis. This study identifies miR-5188 as a novel oncomiR and provides a new theoretical basis for the clinical use of miR-5188 antagonists in the treatment of breast cancer.
Copyright © 2019 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FOXO1; breast cancer; cancer stem cells; miR-5188; stemness; timeless; ubiquitination; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31604679      PMCID: PMC6951841          DOI: 10.1016/j.ymthe.2019.08.015

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  47 in total

1.  Redirecting TGF-β Signaling through the β-Catenin/Foxo Complex Prevents Kidney Fibrosis.

Authors:  Xi Qiao; Padmashree Rao; Yun Zhang; Lixin Liu; Min Pang; Hailong Wang; Min Hu; Xinrui Tian; Jianlin Zhang; Ye Zhao; Xin Maggie Wang; Chengshi Wang; Hong Yu; Fei Guo; Qi Cao; Yiping Wang; Yuan Min Wang; Geoff Yu Zhang; Vincent W Lee; Stephen I Alexander; Guoping Zheng; David C H Harris
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

2.  circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.

Authors:  Yuting Sang; Bing Chen; Xiaojin Song; Yaming Li; Yiran Liang; Dianwen Han; Ning Zhang; Hanwen Zhang; Ying Liu; Tong Chen; Chen Li; Lijuan Wang; Wenjing Zhao; Qifeng Yang
Journal:  Mol Ther       Date:  2019-05-17       Impact factor: 11.454

3.  Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells.

Authors:  Jie Zhu; Peng Wang; Zhimin Yu; Wei Lai; Yi Cao; Pinbo Huang; Qiaodong Xu; Menglei Yu; Junyao Xu; Zitong Huang; Bing Zeng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 4.  The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

Authors:  Vicki Plaks; Niwen Kong; Zena Werb
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

5.  Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.

Authors:  Hongran Yin; Gaofeng Xiong; Sijin Guo; Congcong Xu; Ren Xu; Peixuan Guo; Dan Shu
Journal:  Mol Ther       Date:  2019-04-25       Impact factor: 11.454

6.  TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival.

Authors:  Kenya Yoshida; Mitsuo Sato; Tetsunari Hase; Momen Elshazley; Ryo Yamashita; Noriyasu Usami; Tetsuo Taniguchi; Kohei Yokoi; Shigeo Nakamura; Masashi Kondo; Luc Girard; John D Minna; Yoshinori Hasegawa
Journal:  Cancer Sci       Date:  2013-01-07       Impact factor: 6.716

7.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Authors:  Francesca Zanconato; Mattia Forcato; Giusy Battilana; Luca Azzolin; Erika Quaranta; Beatrice Bodega; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2015-08-10       Impact factor: 28.824

8.  Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.

Authors:  Zhong Chen; Xun Lan; Dayong Wu; Benjamin Sunkel; Zhenqing Ye; Jiaoti Huang; Zhihua Liu; Steven K Clinton; Victor X Jin; Qianben Wang
Journal:  Nat Commun       Date:  2015-09-16       Impact factor: 14.919

9.  Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.

Authors:  Liqun Chen; Lilly Y W Bourguignon
Journal:  Mol Cancer       Date:  2014-03-08       Impact factor: 27.401

Review 10.  Regulation of microRNA function in animals.

Authors:  Luca F R Gebert; Ian J MacRae
Journal:  Nat Rev Mol Cell Biol       Date:  2019-01       Impact factor: 94.444

View more
  19 in total

Review 1.  Co-regulation of circadian clock genes and microRNAs in bone metabolism.

Authors:  Tingting Li; Shihua Zhang; Yuxuan Yang; Lingli Zhang; Yu Yuan; Jun Zou
Journal:  J Zhejiang Univ Sci B       Date:  2022-07-15       Impact factor: 5.552

2.  MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.

Authors:  Fangfang Li; Chen Zhao; Yuchao Diao; Zixiang Wang; Jiali Peng; Ning Yang; Chunping Qiu; Beihua Kong; Yingwei Li
Journal:  Cell Death Dis       Date:  2022-06-17       Impact factor: 9.685

3.  The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.

Authors:  Jia-Hao Liu; Hui-Ling Yang; Shu-Ting Deng; Zhe Hu; Wei-Feng Chen; Wei-Wei Yan; Ren-Tao Hou; Yong-Hao Li; Rui-Ting Xian; Ying-Ying Xie; Yun Su; Li-Yang Wu; Ping Xu; Zhi-Bo Zhu; Xiong Liu; Yu-Ling Deng; Yu-Bing Wang; Zhen Liu; Wei-Yi Fang
Journal:  Acta Pharmacol Sin       Date:  2022-03-16       Impact factor: 7.169

4.  Bioinformatics Analysis Reveals Biomarkers With Cancer Stem Cell Characteristics in Lung Squamous Cell Carcinoma.

Authors:  Yi Liao; Hua Xiao; Mengqing Cheng; Xianming Fan
Journal:  Front Genet       Date:  2020-05-13       Impact factor: 4.599

5.  MicroRNA-4476 promotes glioma progression through a miR-4476/APC/β-catenin/c-Jun positive feedback loop.

Authors:  Jie Lin; Shengfeng Ding; Cheng Xie; Renhui Yi; Zhiyong Wu; Jie Luo; Tengyue Huang; Yu Zeng; Xizhao Wang; Anqi Xu; Jianqi Xiao; Ye Song; Xian Zhang
Journal:  Cell Death Dis       Date:  2020-04-23       Impact factor: 8.469

6.  lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling.

Authors:  Ting Tang; Ling-Xing Wang; Mei-Li Yang; Rong-Mou Zhang
Journal:  Mol Med Rep       Date:  2020-09-28       Impact factor: 2.952

7.  miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.

Authors:  Renhui Yi; Shaochun Yang; Xian Lin; Liangying Zhong; Yuanyuan Liao; Zheng Hu; Tengyue Huang; Hao Long; Jie Lin; Zhiyong Wu; Cheng Xie; Shengfeng Ding; Jie Luo; Qisheng Luo; Ye Song
Journal:  J Cell Mol Med       Date:  2020-09-09       Impact factor: 5.310

8.  Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis.

Authors:  Yanhong Wang; Qian Wang; Xibei Li; Gongwen Luo; Mou Shen; Jia Shi; Xueliang Wang; Lu Tang
Journal:  Drug Des Devel Ther       Date:  2021-01-22       Impact factor: 4.162

Review 9.  EMT-associated microRNAs and their roles in cancer stemness and drug resistance.

Authors:  Guangtao Pan; Yuhan Liu; Luorui Shang; Fangyuan Zhou; Shenglan Yang
Journal:  Cancer Commun (Lond)       Date:  2021-01-27

Review 10.  The Wnt Signalling Pathway: A Tailored Target in Cancer.

Authors:  Malvina Koni; Veronica Pinnarò; Maria Felice Brizzi
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.